Post-Transplant Lymphoproliferative Disorders (PTLD) in Pediatric Heart Transplantation
Author:
Affiliation:
1. Department of Transplant Medicine, National Cerebral and Cardiovascular Center
Publisher
The Japanese Society of Pediatric Cardiology and Cardiac Surgery
Subject
Polymers and Plastics,General Environmental Science
Link
https://www.jstage.jst.go.jp/article/jspccs/37/2/37_EC2020-0028/_pdf
Reference6 articles.
1. 1) Gao SZ, Chaparro SV, Perlroth M, et al: Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003; 22: 505–514
2. 2) Boucek MM, Edwards LB, Keck BM, et al: The registry of the international society for heart and lung transplantation: Sixth official pediatric report-2003. J Heart Lung Transplant 2003; 22: 636–652
3. 3) Majewski M, Korecka M, Joergensen J, et al: Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation 2003; 75: 1710–1717
4. 4) Kusuki S, Hashii Y, Fukushima N, et al: Pediatric post-transplant diffuse large B cell lymphoma after cardiac transplantation. Int J Hematol 2009; 89: 209–213
5. 5) 石橋誠二郎,中野克俊,浦田 晋,ほか:末梢血のEBウイルス感染細胞同定解析に基づき早期に治療開始できた心臓移植後リンパ増殖性疾患の一例.日小児循環器会誌2021; 37: 133–140
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3